The Journal of Haemophilia Practice

The Journal of Haemophilia Practice is owned and managed by Haemnet Ltd.

Editor-in-Chief
Dr Kate Khair, Haemnet Ltd, London, UK

Managing Editor
Mike Holland, Haemnet Ltd, London, UK
mike@haemnet.com

Technical Editor
Kathryn Jenner, Haemnet Ltd, London, UK
kathryn@haemnet.com

Editorial Advisory Board
Sulochana B, Manipal College of Nursing, India
Tami Barazani-Brutman, Sheba Medical Center at Sheba, Tel Hashomer Hospital, Israel
Paul Batty, University College London, UK
Petra Bučková, University Hospital Brno, Czechia
Erica Crilly, British Columbia Children's Hospital, Vancouver, Canada
Saliou Diop, Cheikh Anta Diop University, Dakar, Senegal
Marcela Ganzella-Sisdelli, Fundaçao Hemocentro de Ribeirao Preto, Brazil
Rich Gorman, Brighton and Sussex Medical School, UK
Cathy Harrison, Royal Hallamshire Hospital, Sheffield, UK
Adam Jones, University of Sunderland, UK
Radek Kaczmarek, Indiana University School of Medicine, USA
Paula Loughnane, OLCHC, Trinity College Dublin, Ireland
Paul McLaughlin, Royal Free Hospital, London, UK
Wolfgang Miesbach, Frankfurt University Hospital, Germany
Greta Mulders, Erasmus University Medical Center, Rotterdam, The Netherlands
Jamie O'Hara, University of Chester, UK
Mohsena Olath, Haemophilia Association of Mauritius
Debra Pollard, Royal Free Hospital, London, UK
BJ Ramsay, Wellington Haemophilia Centre, Wellington, New Zealand
Robyn Shoemark, Children’s Hospital at Westmead, Sydney, Australia
Karen Strike, Hamilton Health Sciences, McMaster Children’s Hospital, Ontario, Canada
Linda Myrin Westesson, Sahlgrenska University Hospital, Gothenburg, Sweden
Sally-Anne Wherry, University of Gloustershire, Cheltenham, UK

Publisher
Haemnet Ltd

Publishing Services Provider
Sciendo, Subsidiary of Walter de Gruyter GmbH

The Journal of Haemophilia Practice is covered by the following services:

• Baidu Scholar
• Cabell's Journalytics
• CINAHL
• CNKI Scholar (China National Knowledge Infrastructure)
• CNPIEC - cnpLINKer
• Dimensions
• DOAJ (Directory of Open Access Journals)
• EBSCO
• ExLibris
• Google Scholar
• J-Gate
• JournalTOCs
• KESLI-NDSL (Korean National Discovery for Science Leaders)
• MyScienceWork
• Naver Academic
• Naviga (Softweco)
• QOAM (Quality Open Access Market)
• ReadCube
• SCILIT
• Semantic Scholar
• Sherpa/RoMEO
• TDNet
• Ulrich's Periodicals Directory/ulrichsweb
• WorldCat (OCLC)
• X-MOL

Additionally, the journal is registered and indexed in the Crossref database.

Manuscripts should be submitted via the journal’s Scholar One Manuscripts site: mc04.manuscriptcentral.com/jhaempract.

You will need to log in. If you are using Scholar One for the first time, use the ‘Create an Account’ link.

One you have logged in, select the ‘Author’ tab. You should then follow the on-screen instructions – the system will guide you through the process of manuscript submission. Alongside the manuscript, accompanying figures and tables, and general information about the manuscript, you will be asked to provide:

• The names of suggested reviewers (optional)
• A cover letter signed on behalf of all co-authors by the corresponding author
• An Open Access License agreement, completed by the corresponding author on behalf of all co-authors (available via the ‘Instructions and Forms’ tab on the journal’s Scholar One Manuscripts site: mc04.manuscriptcentral.com/jhaempract)
• Details of any conflicts of interest
• Confirmation that informed consent has been obtained where appropriate.

After submitting your manuscript, you will receive a confirmation email.

You can check on the status of your manuscript at any time by logging in to your Scholar One account.

The journal will notify you by email when a decision has been made on your manuscript.

Copyright

Copyright in all articles published in The Journal of Haemophilia Practice is retained by the authors. This does not contradict licensing terms or the terms of the open access policy under which the journal is published.
Authors grant The Journal of Haemophilia Practice the right of first publication.
Authors may enter into other contractual arrangements for non-exclusive distribution of The Journal of Haemophilia Practice’s published version of their work, providing its initial publication in the Journal is acknowledged.
Authors are permitted and encouraged to post their work online (e.g. in an institutional repository or on their own website) prior to or during the submission process, as this can lead to productive exchanges as well as positively impacting earlier and greater citation of published work.
For further information on the journal’s editorial policies and publication ethics, please see documentation listed under the ‘For Authors’ tab.

Manuscript types

The Journal of Haemophilia Practice accepts

• Original research
• Case reports
• Case series
• Reviews in any field of bleeding disorders of relevance to current clinical practice
• Clinical Updates that describe current advances in any clinical field related to bleeding disorders
• Editorials that address a particular topic of current interest.

Please note that case reports should meet the standards outlined in the CARE Case Report Guidelines. Authors submitting case reports are advised to consult the CARE Checklist.

Manuscript format

Wordcount

Although we do not specify wordcounts for articles, we recommend the following:

• For shorter papers, e.g. case reports and small cohort studies: 1,000–3,000 words
• For reviews, larger studies and qualitative studies, which require explanation of methodologies: 3,000–7,000 words.

Title

The title should be short and informative. For case reports, the words ‘case report’ should be included in the title.

Authors

Full author names and affiliation should be given. An ORCID iD for each author should be provided where available.

Abstract

For original articles, a short abstract should be provided using the following headings: Background or Introduction, Aims, Methods, Results, Conclusion.

Keywords

Submissions should include 3–6 keywords for indexing purposes.

Reference style

Journal titles should be abbreviated according to the style of Index Medicus and spelled out in full if not listed in Index Medicus. These can be looked up in the NLM Catalog.

The DOI (digital object identifier) associated with journal articles should be provided where available.

Where there are six or more authors associated with a reference, the first three should be listed, followed by ‘et al.’

Datasets should be cited using the format outlined by the Joint Declaration of Data Citation Principles: Authors; Year; Dataset title; Data repository/archive; Version (if relevant); Persistent identifier, e.g. DOI (if available).

Reference style examples:

• Reference to an article:

Khair K, Klukowska A, Myrin Westesson L, et al. The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study). Haemophilia 2019; 25(3): 416-423. doi: 10.1111/hae.13736.

• Reference to a book:

Jones P. Living with Haemophilia. 2002. Oxford: Oxford University Press.

• Reference to a chapter in a book:

Escobar MA, Roberts HR. Less common congenital disorders of hemostasis. In: Kitchens CS, ed. Consultative Hemostasis and Thrombosis, 3rd edn. 2013. Philadelphia, PA: W.B. Saunders Company.

• Reference to a webpage/online resource:

European Medicines Agency (EMA). European Public Assessment Report (EPAR) NovoSeven Summary for the Public. 2009. Available from http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000074/human_med_000936.jsp&mid=WC0b01ac058001d124 (accessed 9 September 2013).

Figures and tables

Please provide tables and figures at the end of the manuscript or as a separate file.

Informed consent

People who are reported in studies have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, dates of birth or hospital numbers, should not be published in written descriptions, photographs or pedigrees unless the information is essential for scientific purposes and the person (or parent or guardian) gives written informed consent for publication.

Informed consent for this purpose requires that an identifiable person be shown the manuscript to be submitted for publication. Authors should disclose to these participants whether any potential identifiable material might be available via the internet or in print after publication.

Each implicated individual’s consent should be written and archived with the authors. If the patient is a minor or lacks capacity to consent, the written informed consent of a parent or guardian must be given. If the person in the case study is deceased, written consent must be sought from a relative. Without consent, a case report may be considered for publication if the patient is sufficiently anonymised according to ICMJE guidelines. Nonessential identifying details should always be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.

Consent must be mentioned in the manuscript. We reserve the right to request copies of consent documentation. The Editor will make the final determination of what constitutes personally identifiable information on a case-by-case basis.

Open Access Statement

The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users.

Open Access License